-
1
-
-
15444366255
-
Polycystic ovary syndrome
-
Ehrmann, D.A. Polycystic ovary syndrome. N. Engl. J. Med., 2005, 352, 1223-1236.
-
(2005)
N. Engl. J. Med.
, vol.352
, pp. 1223-1236
-
-
Ehrmann, D.A.1
-
2
-
-
1442303475
-
Androgen excess in women: Experience with over 1000 consecutive patients
-
Azziz, R.; Sanchez, L.A.; Knochenhauer, E.S.; Moran, C.; Lazenby, J.; Stephens, K.C.; Taylor, K.; Boots, L.R. Androgen excess in women: experience with over 1000 consecutive patients. J. Clin. Endocrinol. Metab., 2004, 89, 453-462.
-
(2004)
J. Clin. Endocrinol. Metab.
, vol.89
, pp. 453-462
-
-
Azziz, R.1
Sanchez, L.A.2
Knochenhauer, E.S.3
Moran, C.4
Lazenby, J.5
Stephens, K.C.6
Taylor, K.7
Boots, L.R.8
-
3
-
-
42049113856
-
Evaluation and treatment of hirsutism in premenopausal women: An endocrine society clinical practice guideline
-
Martin, K.A.; Chang, R.J.; Ehrmann, D.A.; Ibanez, L.; Lobo, R.A.; Rosenfield, R.L.; Shapiro, J.; Montori, V.M.; Swiglo, B.A. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab., 2008, 93, 1105-1120.
-
(2008)
J. Clin. Endocrinol. Metab.
, vol.93
, pp. 1105-1120
-
-
Martin, K.A.1
Chang, R.J.2
Ehrmann, D.A.3
Ibanez, L.4
Lobo, R.A.5
Rosenfield, R.L.6
Shapiro, J.7
Montori, V.M.8
Swiglo, B.A.9
-
4
-
-
0037205511
-
Hyperandrogenaemia and the ovary
-
Norman, R.J. Hyperandrogenaemia and the ovary. Mol. Cell Endocrinol., 2002, 191, 113-119.
-
(2002)
Mol. Cell Endocrinol.
, vol.191
, pp. 113-119
-
-
Norman, R.J.1
-
5
-
-
0028173882
-
Steroid 5alpha-reductase: Two genes/two enzymes
-
Russell, D.W.; Wilson, J.D. Steroid 5 alpha-reductase: two genes/two enzymes. Annu. Rev. Biochem., 1994, 63, 25-61. (Pubitemid 2109098)
-
(1994)
Annual Review of Biochemistry
, vol.63
, pp. 25-61
-
-
Russell, D.W.1
Wilson, J.D.2
-
6
-
-
0025303307
-
Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases
-
DOI 10.1073/pnas.87.10.3640
-
Andersson, S.; Russell, D.W. Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductases. Proc. Natl. Acad. Sci. U. S. A., 1990, 87, 3640-3644. (Pubitemid 20182514)
-
(1990)
Proceedings of the National Academy of Sciences of the United States of America
, vol.87
, Issue.10
, pp. 3640-3644
-
-
Andersson, S.1
Russell, D.W.2
-
7
-
-
33845318187
-
Trends in the development of new drugs for treatment of benign prostatic hyperplasia
-
DOI 10.2174/092986706779010315
-
Kulig, K; Malawska, B. Trends in the development of new drugs for treatment of benign prostatic hyperplasia. Curr. Med. Chem., 2006, 13, 3395-3416. (Pubitemid 44873752)
-
(2006)
Current Medicinal Chemistry
, vol.13
, Issue.28
, pp. 3395-3416
-
-
Kulig, K.1
Malawska, B.2
-
8
-
-
0022390704
-
Species differences in prostatic steroid 5α-reductases of rat, dog, and human
-
Liang, T.; Cascieri, M.A.; Cheung, A.H.; Reynolds, G.F.; Rasmusson, G.H. Species differences in prostatic steroid 5 alpha-reductases of rat, dog, and human. Endocrinology 1985, 117, 571-579. (Pubitemid 15237874)
-
(1985)
Endocrinology
, vol.117
, Issue.2
, pp. 571-579
-
-
Liang, T.1
Cascieri, M.A.2
Cheung, A.H.3
-
9
-
-
0023547344
-
Towards the mapping of the progesterone and androgen receptors
-
Ojasoo, T.; Delettre, J.; Mornon, J.P.; Turpin-VanDycke, C.; Raynaud, J.P. Towards the mapping of the progesterone and androgen receptors. J.Steroid Biochem., 1987, 27, 255-269.
-
(1987)
J.Steroid Biochem.
, vol.27
, pp. 255-269
-
-
Ojasoo, T.1
Delettre, J.2
Mornon, J.P.3
Turpin-VanDycke, C.4
Raynaud, J.P.5
-
10
-
-
34548062694
-
Design, synthesis, and in vivo SAR of a novel series of pyrazolines as potent selective androgen receptor modulators
-
DOI 10.1021/jm0613976
-
Zhang, X.; Li, X.; Allan, G.F.; Sbriscia, T.; Linton, O.; Lundeen, S.G.; Sui, Z. Design, synthesis, and in vivo SAR of a novel series of pyrazolines as potent selective androgen receptor modulators. J. Med. Chem., 2007, 50, 3857-3869. (Pubitemid 47292049)
-
(2007)
Journal of Medicinal Chemistry
, vol.50
, Issue.16
, pp. 3857-3869
-
-
Zhang, X.1
Li, X.2
Allan, G.F.3
Sbriscia, T.4
Linton, O.5
Lundeen, S.G.6
Sui, Z.7
-
11
-
-
0028033594
-
The length and location of CAG trinucleotide repeats in the androgen receptor Nterminal domain affect transactivation function
-
Chamberlain, N.L.; Driver, E.D.; Miesfeld, R.L. The length and location of CAG trinucleotide repeats in the androgen receptor Nterminal domain affect transactivation function. Nucleic Acids Res., 1994, 22, 3181-3186.
-
(1994)
Nucleic Acids Res.
, vol.22
, pp. 3181-3186
-
-
Chamberlain, N.L.1
Driver, E.D.2
Miesfeld, R.L.3
-
12
-
-
0028922314
-
Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: Possible pathogenetic relevance for the (CAG)n-expanded neuronopathies
-
Kazemi-Esfarjani, P.; Trifiro, M.A.; Pinsky, L. Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum. Mol. Genet., 1995, 4, 523-527.
-
(1995)
Hum. Mol. Genet.
, vol.4
, pp. 523-527
-
-
Kazemi-Esfarjani, P.1
Trifiro, M.A.2
Pinsky, L.3
-
13
-
-
0033978514
-
Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length
-
Irvine R.A, Ma H, Yu M.C, Ross R.K, Stallcup M.R, Coetzee G.A. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Hum. Mol. Genet., 2000, 9, 267-274. (Pubitemid 30052750)
-
(2000)
Human Molecular Genetics
, vol.9
, Issue.2
, pp. 267-274
-
-
Irvine, R.A.1
Ma, H.2
Yu, M.C.3
Ross, R.K.4
Stallcup, M.R.5
Coetzee, G.A.6
-
14
-
-
0037622753
-
Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism
-
DOI 10.1210/jc.2002-021791
-
Ibanez, L.; Ong, K.K.; Mongan, N.; Jaaskelainen, J.; Marcos, M.V.; Hughes, I.A.; De, Z.F.; Dunger, D.B. Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism. J. Clin. Endocrinol. Metab., 2003, 88, 3333-3338. (Pubitemid 36877513)
-
(2003)
Journal of Clinical Endocrinology and Metabolism
, vol.88
, Issue.7
, pp. 3333-3338
-
-
Ibanez, L.1
Ong, K.K.2
Mongan, N.3
Jaaskelainen, J.4
Marcos, M.V.5
Hughes, I.A.6
De Zegher, F.7
Dunger, D.B.8
-
15
-
-
0031829734
-
Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne
-
Sawaya, M.E.; Shalita, A.R. Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne. J. Cutan. Med. Surg., 1998, 3, 9-15.
-
(1998)
J. Cutan. Med. Surg.
, vol.3
, pp. 9-15
-
-
Sawaya, M.E.1
Shalita, A.R.2
-
16
-
-
49649108560
-
Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility
-
Wu, M.H.; Chou, Y.C.; Yu, C.P.; Yang, T.; You, S.L.; Chen, C.J.; Sun, C.A. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility. Eur. J. Cancer Prev., 2008, 17, 317-322.
-
(2008)
Eur. J. Cancer Prev.
, vol.17
, pp. 317-322
-
-
Wu, M.H.1
Chou, Y.C.2
Yu, C.P.3
Yang, T.4
You, S.L.5
Chen, C.J.6
Sun, C.A.7
-
17
-
-
0034976483
-
Polymorphisms of the androgen receptor gene and the estrogen receptor β gene are associated with androgen levels in women
-
DOI 10.1210/jc.86.6.2562
-
Westberg, L.; Baghaei, F.; Rosmond, R.; Hellstrand, M.; Landen, M.; Jansson, M.; Holm, G.; Bjorntorp, P.; Eriksson, E. Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women. J. Clin. Endocrinol. Metab., 2001, 86, 2562-2568. (Pubitemid 32545707)
-
(2001)
Journal of Clinical Endocrinology and Metabolism
, vol.86
, Issue.6
, pp. 2562-2568
-
-
Westberg, L.1
Baghaei, F.2
Rosmond, R.3
Hellstrand, M.4
Landen, M.5
Jansson, M.6
Holm, G.7
Bjorntorp, P.8
Eriksson, E.9
-
18
-
-
8344226282
-
Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance
-
He, B.; Gampe, R.T. Jr.; Kole, A.J.; Hnat, A.T.; Stanley, T.B.; An, G.; Stewart, E.L.; Kalman, R.I.; Minges, J.T.; Wilson, E.M. Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance. Mol. Cell, 2004, 16, 425-438.
-
(2004)
Mol. Cell
, vol.16
, pp. 425-438
-
-
He, B.1
Gampe Jr., R.T.2
Kole, A.J.3
Hnat, A.T.4
Stanley, T.B.5
An, G.6
Stewart, E.L.7
Kalman, R.I.8
Minges, J.T.9
Wilson, E.M.10
-
19
-
-
20044394709
-
The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor
-
Estebanez-Perpina, E.; Moore, J.M.; Mar, E.; Gado-Rodrigues, E.; Nguyen, P.; Baxter, J.D.; Buehrer, B.M.; Webb, P.; Fletterick, R.J.; Guy, R.K. The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor. J. Biol. Chem., 2005, 280, 8060-8068.
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 8060-8068
-
-
Estebanez-Perpina, E.1
Moore, J.M.2
Mar, E.3
Gado-Rodrigues, E.4
Nguyen, P.5
Baxter, J.D.6
Buehrer, B.M.7
Webb, P.8
Fletterick, R.J.9
Guy, R.K.10
-
20
-
-
0034121290
-
Androgen receptor antagonists (antiandrogens): Structure-activity relationships
-
Singh, S.M.;Gauthier. S; Labrie; F. Androgen receptor antagonists (antiandrogens): structure-activity relationships. Curr. Med. Chem., 2000, 7, 211-247
-
(2000)
Curr. Med. Chem.
, vol.7
, pp. 211-247
-
-
Singh, S.M.1
Gauthier, S.2
Labrie, F.3
-
21
-
-
22244455430
-
The structural basis of androgen receptor activation: Intramolecular and intermolecular amino-carboxy interactions
-
Schaufele, F.; Carbonell, X.; Guerbadot, M.; Borngraeber, S.; Chapman, M.S.; Ma, A.A.; Miner, J.N.; Diamond, M.I. The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions. Proc. Natl. Acad. Sci. USA, 2005, 102, 9802-9807.
-
(2005)
Proc. Natl. Acad. Sci. USA
, vol.102
, pp. 9802-9807
-
-
Schaufele, F.1
Carbonell, X.2
Guerbadot, M.3
Borngraeber, S.4
Chapman, M.S.5
Ma, A.A.6
Miner, J.N.7
Diamond, M.I.8
-
22
-
-
0027161982
-
2-terminal and steroid-binding domains
-
Wong, C.I.; Zhou, Z.X.; Sar, M.; Wilson, E.M. Steroid requirement for androgen receptor dimerization and DNA binding. Modulation by intramolecular interactions between the NH2-terminal and steroid- binding domains. J. Biol. Chem., 1993, 268, 19004-19012. (Pubitemid 23273853)
-
(1993)
Journal of Biological Chemistry
, vol.268
, Issue.25
, pp. 19004-19012
-
-
Wong, C.-I.1
Zhou, Z.-X.2
Sar, M.3
Wilson, E.M.4
-
23
-
-
25444496757
-
Chemistry and structural biology of androgen receptor
-
Gao, W.; Bohl, C.E.; Dalton, J.T. Chemistry and structural biology of androgen receptor. Chem. Rev., 2005, 105, 3352-3370.
-
(2005)
Chem. Rev.
, vol.105
, pp. 3352-3370
-
-
Gao, W.1
Bohl, C.E.2
Dalton, J.T.3
-
24
-
-
0030026583
-
Prostate cancer: Current and evolving strategies
-
Cersosimo, R.J.; Carr, D. Prostate cancer: current and evolving strategies. Am. J. Health Syst. Pharm., 1996, 53, 381-396. (Pubitemid 26061815)
-
(1996)
American Journal of Health-System Pharmacy
, vol.53
, Issue.4
, pp. 381-396
-
-
Cersosimo, R.J.1
Carr, D.2
-
25
-
-
0030913442
-
Pharmacological options in the treatment of benign prostatic hyperplasia
-
DOI 10.1021/jm960697s
-
Kenny,B.; Ballard, S.; Blagg, J.; Fox, D. Pharmacological options in the treatment of benign prostatic hyperplasia. J. Med. Chem., 1997, 40, 1293-1315. (Pubitemid 27198078)
-
(1997)
Journal of Medicinal Chemistry
, vol.40
, Issue.9
, pp. 1293-1315
-
-
Kenny, B.1
Ballard, S.2
Blagg, J.3
Fox, D.4
-
26
-
-
0029043487
-
Clinical and endocrine effects of finasteride, a 5 alpha-reductase inhibitor, in women with idiopathic hirsutism
-
Ciotta, L.; Cianci, A.; Calogero, A.E.; Palumbo, M.A.; Marletta, E.; Sciuto, A.; Palumbo, G. Clinical and endocrine effects of finasteride, a 5 alpha-reductase inhibitor, in women with idiopathic hirsutism. Fertil. Steril., 1995, 64, 299-306.
-
(1995)
Fertil. Steril.
, vol.64
, pp. 299-306
-
-
Ciotta, L.1
Cianci, A.2
Calogero, A.E.3
Palumbo, M.A.4
Marletta, E.5
Sciuto, A.6
Palumbo, G.7
-
27
-
-
0029859309
-
Outcome of long-term treatment with the 5α-reductase inhibitor finasteride in idiopathic hirsutism: Clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up
-
Castello, R.; Tosi, F.; Perrone, F.; Negri, C.; Muggeo, M.; Moghetti, P. Outcome of long-term treatment with the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism: clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up. Fertil. Steril., 1996, 66, 734-740. (Pubitemid 26357573)
-
(1996)
Fertility and Sterility
, vol.66
, Issue.5
, pp. 734-740
-
-
Castello, R.1
Tosi, F.2
Perrone, F.3
Negri, C.4
Muggeo, M.5
Moghetti, P.6
-
28
-
-
42549160531
-
A review of hormonal therapy for female pattern (androgenic) alopecia
-
Scheinfeld, N. A review of hormonal therapy for female pattern (androgenic) alopecia. Dermatol. Online J., 2008, 14, 1. (Pubitemid 351588724)
-
(2008)
Dermatology Online Journal
, vol.14
, Issue.3
, pp. 1
-
-
Scheinfeld, N.1
-
29
-
-
37549007228
-
Development of liposomal systems of finasteride for topical applications: Design, characterization, and in vitro evaluation
-
Kumar, R.; Singh, B.; Bakshi, G.; Katare, O.P. Development of liposomal systems of finasteride for topical applications: design, characterization, and in vitro evaluation. Pharm. Dev. Technol., 2007, 12, 591-601.
-
(2007)
Pharm. Dev. Technol.
, vol.12
, pp. 591-601
-
-
Kumar, R.1
Singh, B.2
Bakshi, G.3
Katare, O.P.4
-
30
-
-
4644366496
-
Dutasteride: A potent dual inhibitor of 5-alphareductase for benign prostatic hyperplasia
-
Rabasseda, X. Dutasteride: a potent dual inhibitor of 5-alphareductase for benign prostatic hyperplasia. Drugs Today (Barc.) 2004, 40, 649-661.
-
(2004)
Drugs Today (Barc.)
, vol.40
, pp. 649-661
-
-
Rabasseda, X.1
-
31
-
-
15944382337
-
Recent advances in the chemistry and pharmacological activity of new steroidal antiandrogens and 5α-reductase inhibitors
-
DOI 10.2174/0929867053507306
-
Bratoeff, E.; Cabeza, M.; Ramirez, E.; Heuze, Y.; Flores, E. Recent advances in the chemistry and pharmacological activity of new steroidal antiandrogens and 5 alpha-reductase inhibitors. Curr. Med. Chem. 2005, 12, 927-943. (Pubitemid 40443848)
-
(2005)
Current Medicinal Chemistry
, vol.12
, Issue.8
, pp. 927-943
-
-
Bratoeff, E.1
Cabeza, M.2
Ramirez, E.3
Heuze, Y.4
Flores, E.5
-
32
-
-
2642697958
-
19-Nor-10-azasteroids: A novel class of inhibitors for human steroid 5α-reductases 1 and 2
-
DOI 10.1021/jm960807v
-
Guarna, A.; Belle, C.; Machetti, F.; Occhiato, E.G.; Payne, A.H.; Cassiani, C.; Comerci, A.; Danza, G.; De, B.A.; Dini, S.; Marrucci, A.; Serio, M. 19-nor-10-azasteroids: a novel class of inhibitors for human steroid 5alpha-reductases 1 and 2. J. Med. Chem. 1997, 40, 1112-1129. (Pubitemid 27149265)
-
(1997)
Journal of Medicinal Chemistry
, vol.40
, Issue.7
, pp. 1112-1129
-
-
Guarna, A.1
Belle, C.2
Machetti, F.3
Occhiato, E.G.4
Payne, A.H.5
Cassiani, C.6
Comerci, A.7
Danza, G.8
De Bellis, A.9
Dini, S.10
Marrucci, A.11
Serio, M.12
-
34
-
-
34548656290
-
3,3-Diphenylpentane skeleton as a steroid skeleton substitute: Novel inhibitors of human 5α-reductase 1
-
DOI 10.1016/j.bmcl.2007.07.039, PII S0960894X07008384
-
Hosoda, S.; Hashimoto, Y. 3,3-diphenylpentane skeleton as a steroid skeleton substitute: novel inhibitors of human 5alpha-reductase 1. Bioorg. Med. Chem. Lett., 2007, 17, 5414-5418. (Pubitemid 47398943)
-
(2007)
Bioorganic and Medicinal Chemistry Letters
, vol.17
, Issue.19
, pp. 5414-5418
-
-
Hosoda, S.1
Hashimoto, Y.2
-
35
-
-
9644290864
-
Synthesis and activity of 8-substituted benzo[c]quinolizin-3-ones as dual inhibitors of human 5alpha-reductases 1 and 2
-
Ferrali, A.; Menchi, G.; Occhiato, E.G.; Danza, G.; Mancina, R.; Serio, M.; Guarna, A. Synthesis and activity of 8-substituted benzo[c]quinolizin-3-ones as dual inhibitors of human 5alpha-reductases 1 and 2. Bioorg. Med. Chem. Lett., 2005, 15,145-148.
-
(2005)
Bioorg. Med. Chem. Lett.
, vol.15
, pp. 145-148
-
-
Ferrali, A.1
Menchi, G.2
Occhiato, E.G.3
Danza, G.4
Mancina, R.5
Serio, M.6
Guarna, A.7
-
36
-
-
1542299149
-
Selective non-steroidal inhibitors of 5α-reductase type 1
-
DOI 10.1016/j.jsbmb.2003.10.004, PII S096007600300503X
-
Occhiato, E.G.; Guarna, A.; Danza, G.; Serio, M. Selective nonsteroidal inhibitors of 5 alpha-reductase type 1. J. Steroid Biochem. Mol. Biol,. 2004, 88,1-16. (Pubitemid 38326593)
-
(2004)
Journal of Steroid Biochemistry and Molecular Biology
, vol.88
, Issue.1
, pp. 1-16
-
-
Occhiato, E.G.1
Guarna, A.2
Danza, G.3
Serio, M.4
-
37
-
-
0035833064
-
Biphenyls as surrogates of the steroidal backbone. Part 2: Discovery of a novel family of non-steroidal 5-α-reductase inhibitors
-
DOI 10.1016/S0960-894X(01)00268-2, PII S0960894X01002682
-
Lesuisse, D.; Gourvest, J.F.; Albert, E.; Doucet, B.; Hartmann, C.; Lefrancois, J.M.; Tessier, S.; Tric, B.; Teutsch, G. Biphenyls as surrogates of the steroidal backbone. Part 2: discovery of a novel family of non-steroidal 5-alpha-reductase inhibitors. Bioorg. Med. Chem. Lett., 2001, 11, 1713-1716. (Pubitemid 32568304)
-
(2001)
Bioorganic and Medicinal Chemistry Letters
, vol.11
, Issue.13
, pp. 1713-1716
-
-
Lesuisse, D.1
Gourvest, J.-F.2
Albert, E.3
Doucet, B.4
Hartmann, C.5
Lefrancois, J.-M.6
Tessier, S.7
Tric, B.8
Teutsch, G.9
-
38
-
-
31544462627
-
Novel 5alpha-reductase inhibitors: Synthesis, structure-activity studies, and pharmacokinetic profile of phenoxybenzoylphenyl acetic acids
-
Salem, OI.; Frotscher, M.; Scherer, C.; Neugebauer, A.; Biemel, K.; Streiber, M.; Maas, R.; Hartmann, R.W. Novel 5alpha-reductase inhibitors: synthesis, structure-activity studies, and pharmacokinetic profile of phenoxybenzoylphenyl acetic acids. J. Med. Chem., 2006, 49, 748-759.
-
(2006)
J. Med. Chem.
, vol.49
, pp. 748-759
-
-
Salem, O.I.1
Frotscher, M.2
Scherer, C.3
Neugebauer, A.4
Biemel, K.5
Streiber, M.6
Maas, R.7
Hartmann, R.W.8
-
39
-
-
0036682372
-
Synthesis and evaluation of 2'-substituted 4-(4′-carboxy- or 4′- carboxymethylbenzylidene)-N-acylpiperidines: Highly potent and in vivo active steroid 5alpha-reductase type 2 inhibitors
-
Picard, F.; Barassin, S.; Mokhtarian, A.; Hartmann, R.W. Synthesis and evaluation of 2'-substituted 4-(4′-carboxy- or 4′- carboxymethylbenzylidene)-N-acylpiperidines: highly potent and in vivo active steroid 5alpha-reductase type 2 inhibitors. J. Med. Chem., 2002, 45, 3406-3417.
-
(2002)
J. Med. Chem.
, vol.45
, pp. 3406-3417
-
-
Picard, F.1
Barassin, S.2
Mokhtarian, A.3
Hartmann, R.W.4
-
40
-
-
0036132203
-
5-Phenyl substituted 1- methyl-2-pyridones and 4'-substituted biphenyl-4-carboxylic acids. synthesis and evaluation as inhibitors of steroid-5alpha-reductase type 1 and 2
-
Picard, F.; Schulz, T.; Hartmann, R.W. 5-Phenyl substituted 1- methyl-2-pyridones and 4'-substituted biphenyl-4-carboxylic acids. synthesis and evaluation as inhibitors of steroid-5alpha-reductase type 1 and 2. Bioorg. Med. Chem., 2002, 10, 437-448.
-
(2002)
Bioorg. Med. Chem.
, vol.10
, pp. 437-448
-
-
Picard, F.1
Schulz, T.2
Hartmann, R.W.3
-
41
-
-
0032882503
-
A novel class of inhibitors for human steroid 5α-reductase: Phenoxybenzoic acid derivatives. I
-
Igarashi, S.; Kimura, T.; Naito, R.; Hara, H.; Fujii, M.; Koutoku, H.; Oritani, H.; Mase, T. A novel class of inhibitors for human steroid 5 alpha-reductase: phenoxybenzoic acid derivatives. I. Chem. Pharm. Bull.(Tokyo), 1999, 47, 1073-1080. (Pubitemid 29436756)
-
(1999)
Chemical and Pharmaceutical Bulletin
, vol.47
, Issue.8
, pp. 1073-1080
-
-
Igarashi, S.1
Kimura, T.2
Naito, R.3
Hara, H.4
Fujii, M.5
Koutoku, H.6
Oritani, H.7
Mase, T.8
-
42
-
-
42049103682
-
Clinical review: Antiandrogens for the treatment of hirsutism: A systematic review and metaanalyses of randomized controlled trials
-
Swiglo, B.A.; Cosma, M.; Flynn, D.N.; Kurtz, D.M.; Labella, M.L.; Mullan, R.J.; Erwin, P.J.; Montori, V.M. Clinical review: Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J. Clin. Endocrinol. Metab., 2008, 93, 1153-1160.
-
(2008)
J. Clin. Endocrinol. Metab.
, vol.93
, pp. 1153-1160
-
-
Swiglo, B.A.1
Cosma, M.2
Flynn, D.N.3
Kurtz, D.M.4
Labella, M.L.5
Mullan, R.J.6
Erwin, P.J.7
Montori, V.M.8
-
43
-
-
0036309841
-
Obesity and the polycystic ovary syndrome
-
Gambineri, A.; Pelusi, C.; Vicennati, V.; Pagotto, U.; Pasquali, R. Obesity and the polycystic ovary syndrome. Int. J. Obes. Relat. Metab. Disord., 2002, 26, 883-896.
-
(2002)
Int. J. Obes. Relat. Metab. Disord.
, vol.26
, pp. 883-896
-
-
Gambineri, A.1
Pelusi, C.2
Vicennati, V.3
Pagotto, U.4
Pasquali, R.5
-
44
-
-
0011886496
-
Isolation from the adrenals of a new crystalline hormone with especially high effectiveness on mineral metabolism
-
Simpson, S.A.; Tait, J.F.; Wettstein, A.; Neher, R.; Von, E.J.; Reichstein, T. Isolation from the adrenals of a new crystalline hormone with especially high effectiveness on mineral metabolism.. Experientia, 1953, 9, 333-335.
-
(1953)
Experientia
, vol.9
, pp. 333-335
-
-
Simpson, S.A.1
Tait, J.F.2
Wettstein, A.3
Neher, R.4
Von, E.J.5
Reichstein, T.6
-
45
-
-
0000167622
-
Action of new steroids in blocking effects of aldosterone and desoxycorticosterone on salt
-
Kagawa, C.M.; Cella, J.A.; Van Arman, C.G. Action of new steroids in blocking effects of aldosterone and desoxycorticosterone on salt. Science, 1957, 126, 1015-1016.
-
(1957)
Science
, vol.126
, pp. 1015-1016
-
-
Kagawa, C.M.1
Cella, J.A.2
Van Arman, C.G.3
-
47
-
-
0015912489
-
Adverse reactions to spironolactone. A report from the Boston Collaborative Drug Surveillance Program
-
Greenblatt, D.J.; Koch-Weser, J. Adverse reactions to spironolactone. A report from the Boston Collaborative Drug Surveillance Program. JAMA, 1973, 225, 40-43.
-
(1973)
JAMA
, vol.225
, pp. 40-43
-
-
Greenblatt, D.J.1
Koch-Weser, J.2
-
48
-
-
0034744368
-
Antimineralocorticoid 11β-substituted spirolactones exhibit androgen receptor agonistic activity: A structure function study
-
Nirde, P.; Terouanne, B.; Gallais, N.; Sultan, C.; Auzou, G. Antimineralocorticoid 11beta-substituted spirolactones exhibit androgen receptor agonistic activity: a structure function study. Mol. Pharmacol., 2001, 59, 1307-1313. (Pubitemid 32381610)
-
(2001)
Molecular Pharmacology
, vol.59
, Issue.5
, pp. 1307-1313
-
-
Nirde, P.1
Terouanne, B.2
Gallais, N.3
Sultan, C.4
Auzou, G.5
-
49
-
-
0021909171
-
The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women
-
Lobo, R.A.; Shoupe, D.; Serafini, P.; Brinton, D.; Horton, R. The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women. Fertil. Steril., 1985, 43, 200-205.
-
(1985)
Fertil. Steril.
, vol.43
, pp. 200-205
-
-
Lobo, R.A.1
Shoupe, D.2
Serafini, P.3
Brinton, D.4
Horton, R.5
-
50
-
-
23944505473
-
Spironolactone for hirsutism in polycystic ovary syndrome
-
DOI 10.1345/aph.1G025
-
Christy, N.A.; Franks, A.S.; Cross, L.B. Spironolactone for hirsutism in polycystic ovary syndrome. Ann. Pharmacother., 2005, 39, 1517-1521. (Pubitemid 41197134)
-
(2005)
Annals of Pharmacotherapy
, vol.39
, Issue.9
, pp. 1517-1521
-
-
Christy, N.A.1
Franks, A.S.2
Cross, L.B.3
-
51
-
-
0037379703
-
Mutation of the androgen receptor at amino acid 708 (Gly>Ala) abolishes partial agonist activity of steroidal antiandrogens
-
DOI 10.1124/mol.63.4.791
-
Terouanne, B.; Nirde, P.; Rabenoelina, F.; Bourguet, W.; Sultan, C.; Auzou, G. Mutation of the androgen receptor at amino acid 708 (Gly-->Ala) abolishes partial agonist activity of steroidal antiandrogens. Mol. Pharmacol., 2003, 63, 791-798. (Pubitemid 36368985)
-
(2003)
Molecular Pharmacology
, vol.63
, Issue.4
, pp. 791-798
-
-
Terouanne, B.1
Nirde, P.2
Rabenoelina, F.3
Bourguet, W.4
Sultan, C.5
Auzou, G.6
-
52
-
-
34250365377
-
Crystal structure of the T877A human androgen receptor ligand-binding domain complexed to cyproterone acetate provides insight for ligand-induced conformational changes and structure-based drug design
-
Bohl, C.E.; Wu, Z.; Miller, D.D.; Bell, C.E.; Dalton, J.T. Crystal structure of the T877A human androgen receptor ligand-binding domain complexed to cyproterone acetate provides insight for ligand-induced conformational changes and structure-based drug design. J. Biol. Chem., 2007, 282, 13648-13655.
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 13648-13655
-
-
Bohl, C.E.1
Wu, Z.2
Miller, D.D.3
Bell, C.E.4
Dalton, J.T.5
-
53
-
-
33645395548
-
Glutamic acid 709 substitutions highlight the importance of the interaction between androgen receptor helices H3 and H12 for androgen and antiandrogen actions
-
Georget, V.; Bourguet, W.; Lumbroso, S.; Makni, S.; Sultan, C.; Nicolas, J.C. Glutamic acid 709 substitutions highlight the importance of the interaction between androgen receptor helices H3 and H12 for androgen and antiandrogen actions. Mol. Endocrinol., 2006, 20, 724-734.
-
(2006)
Mol. Endocrinol.
, vol.20
, pp. 724-734
-
-
Georget, V.1
Bourguet, W.2
Lumbroso, S.3
Makni, S.4
Sultan, C.5
Nicolas, J.C.6
-
55
-
-
34247595553
-
Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: Particle characterisation and skin uptake
-
DOI 10.1007/s11095-006-9225-9
-
Stecova, J.; Mehnert, W.; Blaschke, T.; Kleuser, B.; Sivaramakrishnan, R.; Zouboulis, C.C.; Seltmann, H.; Korting, H.C.; Kramer, K.D.; Schafer-Korting, M. Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake. Pharm. Res., 2007, 24, 991-1000. (Pubitemid 46675401)
-
(2007)
Pharmaceutical Research
, vol.24
, Issue.5
, pp. 991-1000
-
-
Stecova, J.1
Mehnert, W.2
Blaschke, T.3
Kleuser, B.4
Sivaramakrishnan, R.5
Zouboulis, C.C.6
Seltmann, H.7
Korting, H.C.8
Kramer, K.D.9
Schafer-Korting, M.10
-
56
-
-
29044448524
-
Chlormadinone acetate (CMA) in oral contraception - A new opportunity
-
DOI 10.1080/13625180500434889
-
Bouchard, P. Chlormadinone acetate in oral contraception - a new opportunity. Eur. J. Contracept. Reprod. Health Care, 2005, 10, 7-11. (Pubitemid 41790961)
-
(2005)
European Journal of Contraception and Reproductive Health Care
, vol.10
, Issue.SUPPL. 1
, pp. 7-11
-
-
Bouchard, P.1
-
57
-
-
0019720284
-
Receptor binding and biological activity of steroidal and nonsteroidal antiandrogens
-
keling, A.E.; Furr, B.J.; Glen, A.T.; Hughes, L.R. Receptor binding and biological activity of steroidal and nonsteroidal antiandrogens. J. Steroid Biochem., 1981, 15, 355-359.
-
(1981)
J. Steroid Biochem.
, vol.15
, pp. 355-359
-
-
Keling, A.E.1
Furr, B.J.2
Glen, A.T.3
Hughes, L.R.4
-
58
-
-
33750996161
-
Update on the management of polycystic ovary syndrome
-
Krysiak, R.; Okopien, B.; Gdula-Dymek, A.; Herman, Z.S. Update on the management of polycystic ovary syndrome. Pharmacol. Rep., 2006, 58, 614-625. (Pubitemid 44741680)
-
(2006)
Pharmacological Reports
, vol.58
, Issue.5
, pp. 614-625
-
-
Krysiak, R.1
Okopien, B.2
Gdula-Dymek, A.3
Herman, Z.S.4
-
59
-
-
0034457586
-
Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: A randomized, double blind, placebo-controlled trial
-
DOI 10.1210/jc.85.1.89
-
Moghetti, P.; Tosi, F.; Tosti, A.; Negri, C.; Misciali, C.; Perrone, F.; Caputo, M.; Muggeo, M.; Castello, R. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial. J. Clin. Endocrinol. Metab., 2000, 85, 89-94. (Pubitemid 32268796)
-
(2000)
Journal of Clinical Endocrinology and Metabolism
, vol.85
, Issue.1
, pp. 89-94
-
-
Moghetti, P.1
Tosi, F.2
Tosti, A.3
Negri, C.4
Misciali, C.5
Perrone, F.6
Caputo, M.7
Muggeo, M.8
Castello, R.9
-
60
-
-
0033305292
-
A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism
-
Venturoli, S.; Marescalchi, O.; Colombo, F.M.; Macrelli, S.; Ravaioli, B.; Bagnoli, A.; Paradisi, R.; Flamigni, C. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism. J. Clin. Endocrinol. Metab., 1999, 84, 1304-1310. (Pubitemid 30648805)
-
(1999)
Journal of Clinical Endocrinology and Metabolism
, vol.84
, Issue.4
, pp. 1304-1310
-
-
Venturoli, S.1
Marescalchi, O.2
Colombo, F.M.3
Macrelli, S.4
Ravaioli, B.5
Bagnoli, A.6
Paradisi, R.7
Flamigni, C.8
-
61
-
-
28944433481
-
Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: A randomized controlled study
-
Inal, M.M.; Yildirim, Y.; Taner, C.E. Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: a randomized controlled study. Fertil. Steril., 2005, 84, 1693-1697.
-
(2005)
Fertil. Steril.
, vol.84
, pp. 1693-1697
-
-
Inal, M.M.1
Yildirim, Y.2
Taner, C.E.3
-
62
-
-
0029863959
-
The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: Evidence that androgens impair insulin action in women
-
DOI 10.1210/jc.81.3.952
-
Moghetti, P.; Tosi, F.; Castello, R.; Magnani, C.M.; Negri, C.; Brun, E.; Furlani, L.; Caputo, M.; Muggeo, M. The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women. J. Clin. Endocrinol. Metab., 1996, 81, 952-960. (Pubitemid 26083953)
-
(1996)
Journal of Clinical Endocrinology and Metabolism
, vol.81
, Issue.3
, pp. 952-960
-
-
Moghetti, P.1
Tosi, F.2
Castello, R.3
Magnani, C.M.4
Negri, C.5
Brun, E.6
Furlani, L.7
Caputo, M.8
Muggeo, M.9
-
63
-
-
0031738513
-
Hormonal effects of flutamide in young women with polycystic ovary syndrome
-
DOI 10.1210/jc.83.1.99
-
De Leo, V.; Lanzetta, D.; D'Antona, D.; la Marca, A.; Morgante, G. Hormonal effects of flutamide in young women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 1998, 83, 99-102. (Pubitemid 28498317)
-
(1998)
Journal of Clinical Endocrinology and Metabolism
, vol.83
, Issue.1
, pp. 99-102
-
-
De Leo, V.1
Lanzetta, D.2
D'Antona, D.3
La Marca, A.4
Morgante, G.5
-
64
-
-
0031726522
-
The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome
-
amanti-Kandarakis, E.; Mitrakou, A.; Raptis, S.; Tolis, G.; Duleba, A.J. The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 1998, 83, 2699-2705.
-
(1998)
J. Clin. Endocrinol. Metab.
, vol.83
, pp. 2699-2705
-
-
Amanti-Kandarakis, E.1
Mitrakou, A.2
Raptis, S.3
Tolis, G.4
Duleba, A.J.5
-
65
-
-
4344635558
-
Flutamide suppresses adrenal steroidogenesis but has no effect on insulin resistance and secretion and lipid levels in overweight women with polycystic ovary syndrome
-
DOI 10.1159/000077827
-
Vrbikova, J.; Hill, M.; Dvorakova, K.; Stanicka, S.; Vondra, K.; Starka, L. Flutamide suppresses adrenal steroidogenesis but has no effect on insulin resistance and secretion and lipid levels in overweight women with polycystic ovary syndrome. Gynecol. Obstet. Invest., 2004, 58, 36-41. (Pubitemid 39140406)
-
(2004)
Gynecologic and Obstetric Investigation
, vol.58
, Issue.1
, pp. 36-41
-
-
Vrbikova, J.1
Hill, M.2
Dvorakova, K.3
Stanicka, S.4
Vondra, K.5
Starka, L.6
-
66
-
-
0036282585
-
The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome
-
Ajossa, S.; Guerriero, S.; Paoletti, A.M.; Orru, M.; Melis, G.B. The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome. Fertil. Steril., 2002, 77, 1136-1140.
-
(2002)
Fertil. Steril.
, vol.77
, pp. 1136-1140
-
-
Ajossa, S.1
Guerriero, S.2
Paoletti, A.M.3
Orru, M.4
Melis, G.B.5
-
67
-
-
70450158339
-
Fulminant Hepatic Failure due to Nilutamide Hepatotoxicity
-
E-pub
-
Merwat, S.N.; Kabbani, W.; Adler, D.G. Fulminant Hepatic Failure due to Nilutamide Hepatotoxicity. Dig. Dis. Sci., 2008. E-pub
-
(2008)
Dig. Dis. Sci.
-
-
Merwat, S.N.1
Kabbani, W.2
Adler, D.G.3
-
68
-
-
33646889289
-
Bicalutamide 150mg: A review of its use in the treatment of locally advanced prostate cancer
-
Wellington, K.; Keam, S.J. Bicalutamide 150mg: a review of its use in the treatment of locally advanced prostate cancer. Drugs, 2006, 66, 837-850.
-
(2006)
Drugs
, vol.66
, pp. 837-850
-
-
Wellington, K.1
Keam, S.J.2
-
69
-
-
0036126649
-
New alternative treatment in hirsutism: Bicalutamide 25 mg/day
-
Muderris, I.I.; Bayram, F.; Ozcelik, B.; Guven, M. New alternative treatment in hirsutism: bicalutamide 25 mg/day. Gynecol. Endocrinol., 2002, 16, 63-66. (Pubitemid 34235024)
-
(2002)
Gynecological Endocrinology
, vol.16
, Issue.1
, pp. 63-66
-
-
Muderris, I.I.1
Bayram, F.2
Ozcelik, B.3
Guven, M.4
-
70
-
-
11244287310
-
Serum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome, and effect of bicalutamide on hirsutism, CRP levels and insulin resistance
-
DOI 10.1159/000081973
-
Bahceci, M.; Tuzcu, A.; Canoruc, N.; Tuzun, Y.; Kidir, V.; Aslan, C. Serum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome, and effect of bicalutamide on hirsutism, CRP levels and insulin resistance. Horm. Res., 2004, 62, 283-287. (Pubitemid 40069627)
-
(2004)
Hormone Research
, vol.62
, Issue.6
, pp. 283-287
-
-
Bahceci, M.1
Tuzcu, A.2
Canoruc, N.3
Tuzun, Y.4
Kidir, V.5
Aslan, C.6
-
71
-
-
34548552533
-
Synthesis and biological evaluation of amino-pyridines as androgen receptor antagonists for stimulating hair growth and reducing sebum production
-
DOI 10.1016/j.bmcl.2007.07.059, PII S0960894X07008591
-
Hu, L.Y.; Lei, H.J.; Du, D.; Johnson, T.R.; Fedij, V.; Kostlan, C.; Yue, W.S.; Lovdahl, M.; Li, J.J.; Carroll, M.; Dettling, D.; Asbill, J.; Fan, C.; Wade, K.; Pocalyko, D.; Lapham, K.; Yalamanchili, R.; Samas, B.; Vrieze, D.; Ciotti, S.; Krieger-Burke, T.; Sliskovic, D.; Welgus, H. Synthesis and biological evaluation of amino-pyridines as androgen receptor antagonists for stimulating hair growth and reducing sebum production. Bioorg. Med. Chem. Lett., 2007, 17, 5693-5697. (Pubitemid 47391296)
-
(2007)
Bioorganic and Medicinal Chemistry Letters
, vol.17
, Issue.20
, pp. 5693-5697
-
-
Hu, L.-Y.1
Lei, H.J.2
Du, D.3
Johnson, T.R.4
Fedij, V.5
Kostlan, C.6
Yue, W.S.7
Lovdahl, M.8
Li, J.J.9
Carroll, M.10
Dettling, D.11
Asbill, J.12
Fan, C.13
Wade, K.14
Pocalyko, D.15
Lapham, K.16
Yalamanchili, R.17
Samas, B.18
Vrieze, D.19
Ciotti, S.20
Krieger-Burke, T.21
Sliskovic, D.22
Welgus, H.23
more..
-
72
-
-
0035938418
-
Synthesis and structure-activity studies of side-chain derivatized arylhydantoins for investigation as androgen receptor radioligands
-
Van Dort, M.E.; Jung, Y.W. Synthesis and structure-activity studies of side-chain derivatized arylhydantoins for investigation as androgen receptor radioligands. Bioorg. Med. Chem. Lett., 2001, 11, 1045-1047.
-
(2001)
Bioorg. Med. Chem. Lett.
, vol.11
, pp. 1045-1047
-
-
Van Dort, M.E.1
Jung, Y.W.2
-
73
-
-
0030698791
-
A controlled study of the effects of RU58841, a non-steroidal antiandrogen, on human hair production by balding scalp grafts maintained on testosterone- conditioned nude mice
-
De, B.B.; Tetelin, C.; Leroy, T.; Bonfils, A.; Van, N.D. A controlled study of the effects of RU58841, a non-steroidal antiandrogen, on human hair production by balding scalp grafts maintained on testosterone- conditioned nude mice. Br. J. Dermatol., 1997, 137, 699-702.
-
(1997)
Br. J. Dermatol.
, vol.137
, pp. 699-702
-
-
De, B.B.1
Tetelin, C.2
Leroy, T.3
Bonfils, A.4
Van, N.D.5
-
74
-
-
0346725827
-
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
-
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril., 2004, 81, 19-25.
-
(2004)
Fertil. Steril.
, vol.81
, pp. 19-25
-
-
-
75
-
-
70450139241
-
The pathogenetic background of polycystic ovary syndrome
-
Reismann, P.; Racz, K. The pathogenetic background of polycystic ovary syndrome. Diabetol. Hung., 2008, 16, 6-13.
-
(2008)
Diabetol. Hung.
, vol.16
, pp. 6-13
-
-
Reismann, P.1
Racz, K.2
-
76
-
-
42449144300
-
Drug Insight: Insulin-sensitizing drugs in the treatment of polycystic ovary syndrome - A reappraisal
-
DOI 10.1038/ncpendmet0787, PII NCPENDMET0787
-
Dunaif, A. Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome - a reappraisal. Nat. Clin. Pract. Endocrinol. Metab., 2008, 4, 272-283. (Pubitemid 351571139)
-
(2008)
Nature Clinical Practice Endocrinology and Metabolism
, vol.4
, Issue.5
, pp. 272-283
-
-
Dunaif, A.1
-
77
-
-
0041736553
-
Metformin: New understandings, new uses
-
Hundal, R.S.; Inzucchi, S.E. Metformin: new understandings, new uses. Drugs, 2003, 63, 1879-1894.
-
(2003)
Drugs
, vol.63
, pp. 1879-1894
-
-
Hundal, R.S.1
Inzucchi, S.E.2
-
78
-
-
28844433635
-
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
-
Shaw, R.J.; Lamia, K.A.; Vasquez, D.; Koo, S.H.; Bardeesy, N.; Depinho, R.A.; Montminy, M.; Cantley, L.C. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science, 2005, 310, 1642-1646.
-
(2005)
Science
, vol.310
, pp. 1642-1646
-
-
Shaw, R.J.1
Lamia, K.A.2
Vasquez, D.3
Koo, S.H.4
Bardeesy, N.5
Depinho, R.A.6
Montminy, M.7
Cantley, L.C.8
-
79
-
-
0034773404
-
Role of AMP-activated protein kinase in mechanism of metformin action
-
DOI 10.1172/JCI200113505
-
Zhou, G.; Myers, R.; Li, Y.; Chen, Y.; Shen, X.; Fenyk-Melody, J.; Wu, M.; Ventre, J.; Doebber, T.; Fujii, N.; Musi, N.; Hirshman, M.F.; Goodyear, L.J.; Moller, D.E. Role of AMP-activated protein kinase in mechanismofmetformin action. J. Clin. Invest., 2001, 108, 1167-1174. (Pubitemid 32995375)
-
(2001)
Journal of Clinical Investigation
, vol.108
, Issue.8
, pp. 1167-1174
-
-
Zhou, G.1
Myers, R.2
Li, Y.3
Chen, Y.4
Shen, X.5
Fenyk-Melody, J.6
Wu, M.7
Ventre, J.8
Doebber, T.9
Fujii, N.10
Musi, N.11
Hirshman, M.F.12
Goodyear, L.J.13
Moller, D.E.14
-
80
-
-
0141724824
-
Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiroinositol) for polycystic ovary syndrome
-
CD003053
-
Lord, J.M.; Flight, I.H.; Norman, R.J. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiroinositol) for polycystic ovary syndrome. Cochrane Database. Syst. Rev., 2003, CD003053.
-
(2003)
Cochrane Database. Syst. Rev.
-
-
Lord, J.M.1
Flight, I.H.2
Norman, R.J.3
-
81
-
-
42049117597
-
Clinical review: Insulin sensitizers for the treatment of hirsutism: A systematic review and metaanalyses of randomized controlled trials
-
Cosma, M.; Swiglo, B.A.; Flynn, D.N.; Kurtz, D.M.; Labella, M.L.; Mullan, R.J.; Elamin, M.B.; Erwin, P.J.; Montori, V.M. Clinical review: Insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J. Clin. Endocrinol. Metab., 2008, 93, 1135-1142.
-
(2008)
J. Clin. Endocrinol. Metab.
, vol.93
, pp. 1135-1142
-
-
Cosma, M.1
Swiglo, B.A.2
Flynn, D.N.3
Kurtz, D.M.4
Labella, M.L.5
Mullan, R.J.6
Elamin, M.B.7
Erwin, P.J.8
Montori, V.M.9
-
82
-
-
33745190800
-
Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in nonobese adolescents and women
-
Ibanez, L.; de Z.F. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in nonobese adolescents and women. Fertil. Steril., 2006, 86(Suppl 1), S24-S25.
-
(2006)
Fertil. Steril.
, vol.86
, Issue.SUPPL. 1
-
-
Ibanez, L.1
De, Z.F.2
-
83
-
-
19244365650
-
Thiazolidinediones
-
Yki-Jarvinen, H. Thiazolidinediones. N. Engl. J. Med., 2004, 351, 1106-1118.
-
(2004)
N. Engl. J. Med.
, vol.351
, pp. 1106-1118
-
-
Yki-Jarvinen, H.1
-
84
-
-
58149269401
-
Insulin-sensitizing agents and reproductive function in polycystic ovary syndrome patients
-
Palomba, S.; Falbo, A.; Orio, F.; Zullo, F. Insulin-sensitizing agents and reproductive function in polycystic ovary syndrome patients. Curr. Opin. Obstet. Gynecol,. 2008, 20, 364-373.
-
(2008)
Curr. Opin. Obstet. Gynecol,.
, vol.20
, pp. 364-373
-
-
Palomba, S.1
Falbo, A.2
Orio, F.3
Zullo, F.4
-
85
-
-
27744483698
-
Direct thiazolidinedione action in the human ovary: Insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production
-
DOI 10.1210/jc.2005-0469
-
Seto-Young, D.; Paliou, M.; Schlosser, J.; Avtanski, D.; Park, A.; Patel, P.; Holcomb, K.; Chang, P.; Poretsky, L. Direct thiazolidinedione action in the human ovary: insulin-independent and insulinsensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production. J. Clin. Endocrinol. Metab., 2005, 90, 6099-6105. (Pubitemid 41606531)
-
(2005)
Journal of Clinical Endocrinology and Metabolism
, vol.90
, Issue.11
, pp. 6099-6105
-
-
Seto-Young, D.1
Paliou, M.2
Schlosser, J.3
Avtanski, D.4
Park, A.5
Patel, P.6
Holcomb, K.7
Chang, P.8
Poretsky, L.9
-
86
-
-
34248174014
-
Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation
-
Yang, C.C.; Wang, Y.C.; Wei, S.; Lin, L.F.; Chen, C.S.; Lee, C.C.; Lin, C.C.; Chen, CS. Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation. Cancer Res., 2007, 67, 3229-3238.
-
(2007)
Cancer Res.
, vol.67
, pp. 3229-3238
-
-
Yang, C.C.1
Wang, Y.C.2
Wei, S.3
Lin, L.F.4
Chen, C.S.5
Lee, C.C.6
Lin, C.C.7
Chen, C.S.8
-
87
-
-
34249852106
-
Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess
-
Ibanez, L.; Lopez-Bermejo, A.; del, R.L.; Enriquez, G.; Valls, C.; de, Z.F. Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess. J. Clin. Endocrinol. Metab., 2007, 92, 1710-1714.
-
(2007)
J. Clin. Endocrinol. Metab.
, vol.92
, pp. 1710-1714
-
-
Ibanez, L.1
Lopez-Bermejo, A.2
Del, R.L.3
Enriquez, G.4
Valls, C.5
De, Z.F.6
-
88
-
-
61649105562
-
Steroid biosynthesis inhibitors in the therapy of hypercortisolism: Theory and Practice
-
Igaz, P.; Tömböl, Z.; Szabo, P.M.; Liko, I.; Racz, K. Steroid biosynthesis inhibitors in the therapy of hypercortisolism: Theory and Practice. Curr. Med. Chem., 2008, 15, 2734-2747
-
(2008)
Curr. Med. Chem.
, vol.15
, pp. 2734-2747
-
-
Igaz, P.1
Tömböl, Z.2
Szabo, P.M.3
Liko, I.4
Racz, K.5
-
89
-
-
0027482984
-
Different inhibitory effect of etomidate and ketoconazole on the human adrenal steroid biosynthesis
-
Weber, M.M.; Lang, J.; Abedinpour, F.; Zeilberger, K.; Adelmann, B.; Engelhardt, D. Different inhibitory effect of etomidate and ketoconazole on the human adrenal steroid biosynthesis. Clin. Investig., 1993, 71, 933-938. (Pubitemid 23327482)
-
(1993)
Clinical Investigator
, vol.71
, Issue.11
, pp. 933-938
-
-
Weber, M.M.1
Lang, J.2
Abedinpour, F.3
Zeilberger, K.4
Adelmann, B.5
Engelhardt, D.6
-
90
-
-
0038778340
-
Three dimensional pharmacophore modeling of human CYP17 inhibitors. Potential agents for prostate cancer therapy
-
Clement, O.O.; Freeman, C.M.; Hartmann, R.W.; Handratta, V.D.; Vasaitis, T.S.; Brodie, A.M.; Njar, V.C. Three dimensional pharmacophore modeling of human CYP17 inhibitors. Potential agents for prostate cancer therapy. J. Med. Chem., 2003, 46, 2345-2351.
-
(2003)
J. Med. Chem.
, vol.46
, pp. 2345-2351
-
-
Clement, O.O.1
Freeman, C.M.2
Hartmann, R.W.3
Handratta, V.D.4
Vasaitis, T.S.5
Brodie, A.M.6
Njar, V.C.7
-
91
-
-
0028328758
-
Ketoconazole therapy: Hormonal and clinical effects in non-tumoral hyperandrogenism
-
idal-Puig, A.J.; Munoz-Torres, M.; Jodar-Gimeno, E.; Garcia- Calvente, C.J.; Lardelli, P.; Ruiz-Requena, M.E.; Escobar-Jimenez, F: Ketoconazole therapy: hormonal and clinical effects in non-tumoral hyperandrogenism. Eur. J. Endocrinol., 1994, 130, 333-338.
-
(1994)
Eur. J. Endocrinol.
, vol.130
, pp. 333-338
-
-
Idal-Puig, A.J.1
Munoz-Torres, M.2
Jodar-Gimeno, E.3
Garcia-Calvente, C.J.4
Lardelli, P.5
Ruiz-Requena, M.E.6
Escobar-Jimenez, F.7
-
92
-
-
0023628779
-
Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease
-
Steingold, K.; De, Z.D.; Cedars, M.; Meldrum, D.R.; Lu, J.K.; Judd, H.L.; Chang, R.J. Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease. J. Clin. Endocrinol. Metab., 1987, 65,773-778.
-
(1987)
J. Clin. Endocrinol. Metab.
, vol.65
, pp. 773-778
-
-
Steingold, K.1
De, Z.D.2
Cedars, M.3
Meldrum, D.R.4
Lu, J.K.5
Judd, H.L.6
Chang, R.J.7
-
93
-
-
0025863589
-
Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome
-
Gonzalez, F.; Hatala, D.A.; Speroff, L. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome. Am. J. Obstet. Gynecol., 1991, 165, 535-545.
-
(1991)
Am. J. Obstet. Gynecol.
, vol.165
, pp. 535-545
-
-
Gonzalez, F.1
Hatala, D.A.2
Speroff, L.3
-
94
-
-
0031029834
-
A long-term treatment with gonadotropinreleasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome
-
Genazzani, A.D.; Petraglia, F.; Battaglia, C.; Gamba, O.; Volpe, A.; Genazzani, A.R. A long-term treatment with gonadotropinreleasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome. Fertil. Steril., 1997, 67, 463-468.
-
(1997)
Fertil. Steril.
, vol.67
, pp. 463-468
-
-
Genazzani, A.D.1
Petraglia, F.2
Battaglia, C.3
Gamba, O.4
Volpe, A.5
Genazzani, A.R.6
-
95
-
-
0030028329
-
Clinical and hormonal effects of gonadotropin-releasing hormone agonist plus an oral contraceptive in severely hirsute patients with polycystic ovary disease
-
Ciotta, L.; Cianci, A.; Giuffrida, G.; Marletta, E.; Agliano, A.; Palumbo, G. Clinical and hormonal effects of gonadotropin-releasing hormone agonist plus an oral contraceptive in severely hirsute patients with polycystic ovary disease. Fertil. Steril., 1996, 65, 61-67.
-
(1996)
Fertil. Steril.
, vol.65
, pp. 61-67
-
-
Ciotta, L.1
Cianci, A.2
Giuffrida, G.3
Marletta, E.4
Agliano, A.5
Palumbo, G.6
-
96
-
-
33646110761
-
Obesity and androgens: Facts and perspectives
-
Pasquali, R. Obesity and androgens: facts and perspectives. Fertil. Steril., 2006, 85, 1319-1340.
-
(2006)
Fertil. Steril.
, vol.85
, pp. 1319-1340
-
-
Pasquali, R.1
-
97
-
-
51649107127
-
Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer
-
Singh, P.; Hallur, G.; Anchoori, R.K.; Bakare, O.; Kageyama, Y.; Khan, S.R.; Isaacs, J.T. Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer. Prostate, 2008, 68, 1570-1581.
-
(2008)
Prostate
, vol.68
, pp. 1570-1581
-
-
Singh, P.1
Hallur, G.2
Anchoori, R.K.3
Bakare, O.4
Kageyama, Y.5
Khan, S.R.6
Isaacs, J.T.7
-
98
-
-
0025061678
-
Molecular cloning and overexpression of the human FK506-binding protein FKBP
-
DOI 10.1038/346671a0
-
Standaert, R.F.; Galat, A.; Verdine, G.L.; Schreiber, S.L. Molecular cloning and overexpression of the human FK506-binding protein FKBP. Nature, 1990, 346, 671-674. (Pubitemid 20266403)
-
(1990)
Nature
, vol.346
, Issue.6285
, pp. 671-674
-
-
Standaert, R.F.1
Galat, A.2
Verdine, G.L.3
Schreiber, S.L.4
-
99
-
-
0033515037
-
Affinity modulation of small-molecule ligands by borrowing endogenous protein surfaces
-
Briesewitz, R.; Ray, G.T.; Wandless, T.J.; Crabtree, G.R. Affinity modulation of small-molecule ligands by borrowing endogenous protein surfaces. Proc. Natl. Acad. Sci. U. S. A., 1999, 96, 1953-1958.
-
(1999)
Proc. Natl. Acad. Sci. U. S. A.
, vol.96
, pp. 1953-1958
-
-
Briesewitz, R.1
Ray, G.T.2
Wandless, T.J.3
Crabtree, G.R.4
-
100
-
-
0032860819
-
Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers
-
Muthuswamy, S.K.; Gilman, M.; Brugge, J.S. Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers. Mol.Cell Biol., 1999, 19, 6845-6857.
-
(1999)
Mol.Cell Biol.
, vol.19
, pp. 6845-6857
-
-
Muthuswamy, S.K.1
Gilman, M.2
Brugge, J.S.3
-
101
-
-
35348812462
-
A surface on the androgen receptor that allosterically regulates coactivator binding
-
DOI 10.1073/pnas.0708036104
-
Estebanez-Perpina, E.; Arnold, L.A.; Nguyen, P.; Rodrigues, E.D.; Mar, E.; Bateman, R.; Pallai, P.; Shokat, K.M.; Baxter, J.D.; Guy, R.K.; Webb, P.; Fletterick, R.J. A surface on the androgen receptor that allosterically regulates coactivator binding. Proc. Natl. Acad. Sci. U. S. A., 2007, 104, 16074-16079. (Pubitemid 350099366)
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, Issue.41
, pp. 16074-16079
-
-
Estebanez-Perpina, E.1
Arnold, L.A.2
Nguyen, P.3
Rodrigues, E.D.4
Mar, E.5
Bateman, R.6
Pallai, P.7
Shokat, K.M.8
Baxter, J.D.9
Guy, R.K.10
Webb, P.11
Fletterick, R.J.12
|